Top and Current
Source: (remove) : MarketBeat
RSS • JSON • XML • CSV
Top and Current
Source: (remove) : MarketBeat
RSS • JSON • XML • CSV

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.


Published on 2025-04-28 08:41:01 - MarketBeat
  Print publication without navigation

  • Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manufacturing.

The article from MSN Money discusses three major pharmaceutical companies, Eli Lilly, Merck, and Bristol Myers Squibb, which are investing over $100 billion in the U.S. Eli Lilly is investing $3.7 billion in a new manufacturing facility in Indiana to increase production of its diabetes and obesity treatments, Mounjaro and Zepbound. Merck is committing $11 billion to expand its manufacturing capabilities in Virginia and North Carolina, focusing on cancer treatments like Keytruda. Bristol Myers Squibb is investing $10 billion in new facilities in Massachusetts and Washington to enhance its production of cancer therapies such as Opdivo and Eliquis. These investments are aimed at meeting growing demand, advancing research, and strengthening the U.S. economy through job creation and innovation in healthcare.

Read the Full MarketBeat Article at:
[ https://www.msn.com/en-us/money/markets/3-top-big-pharma-stocks-investing-over-100-billion-in-the-u-s/ar-AA1DLsvn ]